CD30+ anaplastic large-cell lymphoma wit
β
Cherie H. Dunphy; Laura J. Gardner; Jose L. Manes; Christopher S. Bee; Kutay Tay
π
Article
π
2000
π
John Wiley and Sons
π
English
β 679 KB
CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies. Aberrant CD13 expression has rarely been described